IGMS
Price
$1.32
Change
+$0.08 (+6.45%)
Updated
Jun 6 closing price
Capitalization
74.84M
65 days until earnings call
MRVI
Price
$2.39
Change
+$0.22 (+10.14%)
Updated
Jun 6 closing price
Capitalization
312.43M
66 days until earnings call
Interact to see
Advertisement

IGMS vs MRVI

Header iconIGMS vs MRVI Comparison
Open Charts IGMS vs MRVIBanner chart's image
IGM Biosciences
Price$1.32
Change+$0.08 (+6.45%)
Volume$369.87K
Capitalization74.84M
Maravai LifeSciences Holdings
Price$2.39
Change+$0.22 (+10.14%)
Volume$1.47M
Capitalization312.43M
IGMS vs MRVI Comparison Chart
Loading...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IGMS vs. MRVI commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGMS is a Hold and MRVI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (IGMS: $1.24 vs. MRVI: $2.21)
Brand notoriety: IGMS and MRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IGMS: 47% vs. MRVI: 31%
Market capitalization -- IGMS: $74.84M vs. MRVI: $312.43M
IGMS [@Biotechnology] is valued at $74.84M. MRVI’s [@Biotechnology] market capitalization is $312.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IGMS’s FA Score shows that 0 FA rating(s) are green whileMRVI’s FA Score has 1 green FA rating(s).

  • IGMS’s FA Score: 0 green, 5 red.
  • MRVI’s FA Score: 1 green, 4 red.
According to our system of comparison, MRVI is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IGMS’s TA Score shows that 5 TA indicator(s) are bullish while MRVI’s TA Score has 5 bullish TA indicator(s).

  • IGMS’s TA Score: 5 bullish, 4 bearish.
  • MRVI’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MRVI is a better buy in the short-term than IGMS.

Price Growth

IGMS (@Biotechnology) experienced а +5.08% price change this week, while MRVI (@Biotechnology) price change was -1.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

IGMS is expected to report earnings on Aug 11, 2025.

MRVI is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRVI($312M) has a higher market cap than IGMS($74.8M). MRVI YTD gains are higher at: -59.450 vs. IGMS (-79.705). MRVI has higher annual earnings (EBITDA): -156.92M vs. IGMS (-199.47M). MRVI has more cash in the bank: 322M vs. IGMS (184M). IGMS has less debt than MRVI: IGMS (45.2M) vs MRVI (377M). MRVI has higher revenues than IGMS: MRVI (259M) vs IGMS (2.68M).
IGMSMRVIIGMS / MRVI
Capitalization74.8M312M24%
EBITDA-199.47M-156.92M127%
Gain YTD-79.705-59.450134%
P/E RatioN/AN/A-
Revenue2.68M259M1%
Total Cash184M322M57%
Total Debt45.2M377M12%
TECHNICAL ANALYSIS
Technical Analysis
IGMSMRVI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 11 days ago
77%
MACD
ODDS (%)
Bullish Trend 11 days ago
81%
N/A
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
79%
Bearish Trend 11 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
76%
Advances
ODDS (%)
Bullish Trend 20 days ago
80%
Bullish Trend 19 days ago
77%
Declines
ODDS (%)
Bearish Trend 25 days ago
90%
Bearish Trend 24 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
85%
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
Bearish Trend 11 days ago
89%
Bullish Trend 11 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with MRSN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
+1.64%
MRSN - IGMS
55%
Loosely correlated
+1.64%
CRNX - IGMS
49%
Loosely correlated
+1.39%
DYN - IGMS
47%
Loosely correlated
+0.51%
NTLA - IGMS
43%
Loosely correlated
+3.59%
APLS - IGMS
42%
Loosely correlated
-0.53%
More

MRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRVI has been loosely correlated with CRDF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MRVI jumps, then CRDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRVI
1D Price
Change %
MRVI100%
-0.90%
CRDF - MRVI
42%
Loosely correlated
+2.90%
TECH - MRVI
38%
Loosely correlated
-1.56%
IGMS - MRVI
33%
Loosely correlated
+1.64%
RGNX - MRVI
31%
Poorly correlated
-5.84%
NAUT - MRVI
30%
Poorly correlated
-3.95%
More